Sana Biotechnology (SANA)
Engineers immune-evading cells and in vivo CAR T therapies for diabetes and B-cell disease.
$3.05
vs last close−0.29 (−8.56%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 62.19% | 186.16M shares | |
|---|---|---|---|
| 219 holders · as of Jun 30, 2026 | |||
| Insiders | 3.72% | 11.13M shares | |
| 5 holders · as of Aug 27, 2026 | |||
| Other | 34.09% | 102.07M shares | |
| remainder | |||
299.36M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
219 holders · 186.16M shares · 36 new positions · 103 increased · 65 reduced · 24 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| FMR LLC | 37.43M | 12.50% | −769 | Aug 13, 2026 |
| Flagship Pioneering Inc. | 25.00M | 8.35% | 0 | Aug 14, 2026 |
| Ra Capital Management, L.P. | 18.75M | 6.26% | +18.75Mnew | Aug 14, 2026 |
| BlackRock, Inc. | 16.68M | 5.57% | +2.43M | Aug 7, 2026 |
| State Street Corp | 11.20M | 3.74% | +665.0K | Aug 7, 2026 |
| Canada Pension Plan Investment Board | 10.22M | 3.41% | −3.5K | Aug 14, 2026 |
| Vanguard Capital Management LLC | 8.38M | 2.80% | +940.7K | Aug 13, 2026 |
| Bank of America Corp /DE/ | 5.75M | 1.92% | +2.80M | Aug 14, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| ARCH Venture Fund IX, L.P. | 17.20% | 45.86M | 13G | Nov 14, 2025 |
| RA Capital Management, L.P. | 6.30% | 18.75M | 13G | May 21, 2026 |
| BlackRock, Inc. | 5.10% | 13.64M | 13G | Jan 21, 2026 |
Form 4
Latest trades
No open-market trades in the last 12 months.
House and Senate disclosures
Not reported.